BioNTech has passed on Autolus Therapeutics’ dual targeting CAR-T cell therapy. One year after securing a chance to ...

The "Refractory Metastatic Melanoma - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 4+ companies and 4+ ...

"That was the first time I found out the vaccine was successful - probably one of the most profound moments of my life." In December, UK grandmother Margaret Keenan, 91, became the first person in the ...

U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and EMA marketing authorizations ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Hold rating on Gilead Sciences (GILD – Research Report).

Reports revenue $10.1M, consensus $17.33M. “Reflecting on 2024, it was a year of strong execution leading to significant achievements for ...

For most of America, on March 11, 2020, COVID became real. On that day, The World Health Organization declared the novel coronavirus an official “pandemic.” Two days later, then President Donald Trump ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Arthur Allen KFF Health News National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their grant applications, two researchers said, in a ...

“The latest COVID-19 booster available in New Zealand is the Pfizer-BioNTech’s Comirnaty mRNA vaccine. This targets the Omicron JN.1 variant which is the most common strain currently circulating. This ...

Discover insights from Autolus Therapeutics' Q4 2024 earnings call, featuring AUCATZYL's successful U.S. launch, strong financials, and pipeline updates.

Find Adolescence Review Latest News, Videos & Pictures on Adolescence Review and see latest updates, news, information from NDTV.COM. Explore more on Adolescence Review.